Trial Profile
A Signal of Leukopenia with Ceftaroline in the FDA Adverse Event Reporting System
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2014
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary) ; Beta-lactams
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Adverse reactions
- 08 Apr 2014 New trial record